TherapeuticsMD, Inc. - FORM 10-K - EX-32.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER - March 12, 2015

Attached files

file filename
EX-31.2 - CERTIFICATE OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.ex31-2.htm
EX-31.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc.ex31-1.htm
EX-32.2 - CERTIFICATE OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.ex32-2.htm
EX-1 - FIRST AMENDMENT TO LEASE - TherapeuticsMD, Inc.ex10-36.htm
EXCEL - IDEA: XBRL DOCUMENT - TherapeuticsMD, Inc.Financial_Report.xls
10-K - ANNUAL REPORT - TherapeuticsMD, Inc.txmd-10k_123114.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - TherapeuticsMD, Inc.ex23-1.htm

 

TherapeuticsMD, Inc. 10-K

 

Exhibit 32.1

 

Section 1350 Certification of Chief Executive Officer

 

In connection with the Annual Report of TherapeuticsMD, Inc. (the "Company") on Form 10-K for the year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert G. Finizio, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 12, 2015 /s/ Robert G. Finizio
 

Name: Robert G. Finizio

Title: Chief Executive Officer

  

 

TherapeuticsMD, Inc. Reports

Also read